TV continues to attract pharma’s media spend: Nielsen

Share this article:
Pharmaceutical companies increased spending on network TV by 12% in 2006 compared to 2005, according to figures from Nielsen Media-Plus. The boost in network TV, to $1.8 billion last year, suggests most drug marketers’ confidence in the medium has not waned, despite reports that some companies such as Johnson & Johnson are shifting a larger portion of ad dollars into so-called non-measured media like paid search. Overall, spending in the major media consumer ad category for 2006 rose 14.9% percent over the previous year, to $5.6 billion. Other TV venues continued to draw bigger shares of pharma media budgets, including cable, up 3% to $1.4 billion; syndicated TV, up 31% to $286 million; and spot TV, up 11% to $173 million. Meanwhile, spending on Internet display ads rose 52% but still only accounted for $82 million. Rivaling the TV spend was investment in print, which increased 31% to $1.7 billion last year. As previously reported, the data also revealed: *Pfizer increased its major media consumer ad spending budget by $158 million in 2006, a jump of 32%. *Merck upped its 2006 major media consumer ad budget by $118 million, a 40% increase. *Sepracor’s major media consumer ad budgets grew by $95 million, also a 40% increase.
Share this article:

Email Newsletters

More in News

AstraZenca beefs up respiratory portfolio

AstraZenca beefs up respiratory portfolio

AstraZeneca has made an $875-million move to beef up its respiratory pipeline by making Almirall's lineup its own.

Amgen Q2 sales rise, company to lay off up to 2,900

Amgen Q2 sales rise, company to lay off ...

The majority of the layoffs will be in the US.

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...